Skip to main content
logo
China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
0.1231
+0.0462 (60.08%)
At close: Aug 4, 2026, 4:00 PM EDT
0.0733
-0.0498 (-40.45%)
Pre-market: Aug 5, 2026, 9:13 AM EDT

China SXT Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1.141.141.741.931.972.6
Revenue Growth
-26.00%-34.63%-9.73%-2.19%-24.23%-45.53%
Gross Profit
0.250.250.370.550.431.25
Operating Income
-7.12-7.12-2.68-2.52-5.61-5.19
Net Income
-6.21-6.21-3.3-3.1-5.93-5.74
Earnings Per Share
-9.13-9.13----
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
28.1828.1818.112.0717.3715.52
Total Debt
1.121.120.982.653.762.05
Net Cash (Debt)
27.0527.0517.129.4213.6113.48
Net Cash Growth
35.52%58.08%81.63%-30.77%0.99%1.42%
Net Cash Per Share
39.8139.81----

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-4.02-4.02-2.35-1.93-0.080.27
Capital Expenditures
---0-0.01-0.07-0.06
Free Cash Flow
-4.02-4.02-2.35-1.94-0.150.21
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
21.85%21.85%21.11%28.73%21.62%48.10%
Operating Margin
-625.89%-625.89%-153.97%-130.42%-284.40%-199.43%
Pretax Margin
-545.24%-545.24%-189.77%-160.67%-301.00%-207.82%
Profit Margin
-545.24%-545.24%-189.77%-160.67%-301.00%-195.21%
FCF Margin
-353.01%-353.01%-134.83%-100.34%-7.68%7.91%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
P/FCF Ratio
-----54.69
PS Ratio
3.481.4119.691.931.644.33